Monitoring of a clinical trial

All clinical trials should be monitored. A data safety monitoring board (DSMB) should be created at institution level to monitor adverse events occurring in a clinical trial. It is the responsibility of the investigator to report all adverse events in a clinical trial, in a time bound manner to the IEC and DSMB. The DSMB also reports its findings to the IEC on its own.